文献速递产科

减少Ⅱ类胎心监护图形氧补充倡议的评估

Evaluation of an Initiative to Decrease the Use of Oxygen Supplementation for Category II Fetal Heart Rate Tracings.
PubMed 文献 · Obstet Gynecol · 2021-01-01

这项质量改进研究评估了某城市学术医疗中心2020年1月至7月分娩的1333例产妇,其中干预前474例、干预后859例。实施新指南(不建议对Ⅱ类胎心监护图形且血氧正常的产妇补氧)后,补氧比例从22.6%降至0.6%,达到统计显著的特殊原因变异,且未观察到母胎结局差异。

要点

  • 新指南实施后Ⅱ类胎心监护产妇补氧比例由22.6%降至0.6%。
  • 控制图显示自指南实施当月起出现8点偏移的特殊原因变异,具统计学意义。
  • 所研究的次要母胎结局均无差异,但罕见结局的统计效能有限。

核心结论

  • 对于血氧正常的Ⅱ类胎心监护产妇,不补氧的指南依从性显著提高,且母胎结局无显著变化。

研究设计与样本

  • 质量改进研究,纳入2020年1月1日至7月31日某城市学术医疗中心所有分娩产妇,干预前474例、干预后859例,共1333例。
  • 排除计划剖宫产、多胎妊娠、分娩小于24周、宫内胎儿死亡及因血氧饱和度低于95%而补氧的患者。

主要发现

  • 指南实施前补氧比例为22.6%,实施后为0.6%。
  • 控制图检测到自指南实施当月起出现8点偏移的特殊原因变异,提示统计学显著。
  • 所研究的次要母体或胎儿结局均无差异。

关键数值与推荐

  • 2020年3月20日生效的新指南建议:对Ⅱ类胎心监护图形且无母体低氧血症者不给予母体补氧。
  • 主要结局为产程中接受补氧的患者百分比,采用控制图和特殊原因变异规则分析;P<.05为显著。

临床怎么用

  • 对血氧正常的Ⅱ类胎心监护产妇,可遵循指南不常规补氧,以减少不必要的氧暴露。

局限性

  • 检测不常见结局差异的统计效能有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine compliance with a guideline to reduce exposure to supplemental oxygen for category II fetal heart rate (FHR) tracings in normally oxygenated laboring patients. METHODS: All patients in labor in an urban academic medical center from January 1 to July 31, 2020 were assessed. The preintervention group included those who delivered from January 1 to March 19, 2020. On March 20, 2020, a new guideline took effect that recommended no maternal supplemental oxygen for category II FHR tracings. The postintervention group delivered from March 20 to July 31, 2020. Exclusion criteria were planned cesarean delivery, multiple gestations, delivery at less than 24 weeks of gestation, intrauterine fetal death, and patients who received supplemental oxygen for an oxygen saturation lower than 95%. The primary outcome was the percentage of patients who received oxygen in labor analyzed by control charts and the rules of special cause variation. Chi-squared and t tests were used for secondary outcome assessment. P<.05 was considered significant. RESULTS: A total of 1,333 patients were included, 474 patients in the preintervention group and 859 in the postintervention group. Oxygen was administered to 22.6% of patients before guideline implementation, compared with 0.6% after the guideline. Special cause variation was detected with an 8-point shift starting the month that the guideline was implemented, indicating statistical significance. There were no differences in any studied secondary maternal or fetal outcomes, although our statistical power to detect differences in infrequent outcomes was limited. CONCLUSION: This quality-improvement study demonstrated significant adherence to the guideline that supplemental oxygen would no longer be given to patients with category II FHR tracings in the absence of maternal hypoxemia, with no significant change in maternal or perinatal outcomes.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Burd JE, Anderson K, Berghella V, et al. Evaluation of an Initiative to Decrease the Use of Oxygen Supplementation for Category II Fetal Heart Rate Tracings. Obstet Gynecol. 2021. PMID: 34623075. doi:10.1097/AOG.0000000000004544

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。